Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers

Marie Haddad; Joris Voisin; Claire Reynes; Florence Blanc-Jouvan; Rémi Gressin; Catherine Mansard; Sophie Park; Raphaël Marlu

doi:10.1016/j.thromres.2021.11.013

Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers

Thromb Res. 2022 Jan:209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22.

Authors

Marie Haddad¹, Joris Voisin², Claire Reynes³, Florence Blanc-Jouvan², Rémi Gressin⁴, Catherine Mansard⁵, Sophie Park⁶, Raphaël Marlu⁷

Affiliations

¹ Hemostasis Laboratory, Grenoble Alpes University Hospital Grenoble, France.
² Hematology Laboratory, Annecy Genevois Hospital Center, Annecy, France.
³ Hematology Unit, Annecy Genevois Hospital Center, Annecy, France.
⁴ Department of Hematology, Grenoble Alpes University Hospital, Grenoble, France.
⁵ Department of Internal Medicine, Grenoble Alpes University Hospital, Grenoble, France.
⁶ Department of Hematology, Grenoble Alpes University Hospital, Grenoble, France; Univ. Grenoble Alpes, Faculty of Medicine, Grenoble, France.
⁷ Hemostasis Laboratory, Grenoble Alpes University Hospital Grenoble, France; Univ. Grenoble Alpes, Faculty of Medicine, Grenoble, France. Electronic address: RMarlu@chu-grenoble.fr.

PMID: 34826640
DOI: 10.1016/j.thromres.2021.11.013

No abstract available

Keywords: Acquired Von Willebrand syndrome; Lymphoproliferative disorders; Monoclonal gammopathies; Monoclonal gammopathy of unknown significance (MGUS); Waldenström macroglobulinemia.

Publication types

Letter

MeSH terms

Humans
Lymphoproliferative Disorders* / complications
Monoclonal Gammopathy of Undetermined Significance*
von Willebrand Diseases* / complications
von Willebrand Factor

Substances

von Willebrand Factor